Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors

被引:59
作者
Debast, S. B. [1 ,2 ]
Vaessen, N. [3 ]
Choudry, A. [3 ]
Wiegers-Ligtvoet, E. A. J. [4 ]
van den Berg, R. J. [3 ]
Kuijper, E. J. [3 ]
机构
[1] Meander Med Ctr, Dept Med Microbiol, NL-3800 BM Amersfoort, Netherlands
[2] St Jansdal Hosp, Dept Med Microbiol, Harderwijk, Netherlands
[3] Leiden Univ, Med Ctr, Dept Med Microbiol, Reference Lab Clostridium Difficile,Ctr Infect Di, NL-2300 RA Leiden, Netherlands
[4] St Jansdal Hosp, Dept Pharmacol, Harderwijk, Netherlands
关键词
Antibiotic treatment; antimicrobial stewardship; cephalosporin; Clostridium difficile infection; diarrhoea; outbreak control; quinolone; PROTON PUMP INHIBITORS; TOXINOTYPE-III; DISEASE; DIARRHEA; EPIDEMIOLOGY; INFECTION; STRAIN; FLUOROQUINOLONES; CIPROFLOXACIN; ACQUISITION;
D O I
10.1111/j.1469-0691.2009.02713.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clin Microbiol Infect 2009; 00: 000-000 In the period April-September 2005, an outbreak of Clostridium difficile infection (CDI) due to PCR ribotype 027 occurred among 50 patients in a 341-bed community hospital in Harderwijk, The Netherlands. A retrospective case-control study was performed to identify risk factors specific for CDI, using a group of patients with CDI (n = 45), a group of randomly selected control patients without diarrhoea (n = 90), and a group of patients with non-infectious diarrhoea (n = 109). Risk factors for CDI and for non-CDI diarrhoea were identified using multiple logistic regression analysis. Independent risk factors for CDI were: age above 65 years (OR 2.6; 95% CI 1.0-5.7), duration of hospitalization (OR 1.04 per additional day; 95% CI 1.0-1.1), and antibiotic use (OR 12.5; 95% CI 3.2-48.1). Of the antibiotics used, cephalosporins and fluoroquinolones were identified as the major risk factors for development of CDI. The risk of developing CDI was particularly high in people receiving a combination of a cephalosporin and a fluoroquinolone (OR 57.5; 95% CI 6.8-483.6). The main factors affecting the risk of non-CDI diarrhoea were proton-pump inhibitors, immunosuppressive drugs, underlying digestive system disease, previous surgery, and gastric tube feeding. The outbreak ended only after implementation of restricted use of cephalosporins and a complete ban on fluoroquinolones, in addition to general hygienic measures, cohorting of patients in a separate ward, education of staff, and intensified environmental cleaning. The results of this study support the importance of appropriate antimicrobial stewardship in the control of hospital outbreaks with C. difficile PCR ribotype 027.
引用
收藏
页码:427 / 434
页数:8
相关论文
共 40 条
[1]   Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001 [J].
Archibald, LK ;
Banerjee, SN ;
Jarvis, WR .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (09) :1585-1589
[2]   CIPROFLOXACIN AND CLOSTRIDIUM-DIFFICILE INFECTION [J].
BATES, CJ ;
WILCOX, MH ;
SPENCER, RC ;
HARRIS, DM .
LANCET, 1990, 336 (8724) :1193-1193
[3]   Risk factors for Clostridium difficile infection [J].
Bignardi, GE .
JOURNAL OF HOSPITAL INFECTION, 1998, 40 (01) :1-15
[4]   Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding [J].
Bliss, DZ ;
Johnson, S ;
Savik, K ;
Clabots, CR ;
Willard, K ;
Gerding, DN .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (12) :1012-+
[5]   PSEUDOMEMBRANOUS COLITIS ASSOCIATED WITH CIPROFLOXACIN [J].
CAIN, DB ;
OCONNOR, ME .
LANCET, 1990, 336 (8720) :946-946
[6]   Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea [J].
Cunningham, R ;
Dale, B ;
Undy, B ;
Gaunt, N .
JOURNAL OF HOSPITAL INFECTION, 2003, 54 (03) :243-245
[7]   Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease [J].
Dial, S ;
Delaney, JAC ;
Barkun, AN ;
Suissa, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23) :2989-2995
[8]   Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:: cohort and case-control studies [J].
Dial, S ;
Alrasadi, K ;
Manoukian, C ;
Huang, A ;
Menzies, D .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (01) :33-38
[9]   gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027 [J].
Drudy, Denise ;
Kyne, Lorraine ;
O'Mahony, Rebecca ;
Fanning, Seamus .
EMERGING INFECTIOUS DISEASES, 2007, 13 (03) :504-505
[10]  
DUBBERKE ER, 2007, CLIN INFECT DIS, V15, P45